Myasthenia gravis is a potential complication of immune checkpoint inhibitor therapy
- Posted on: Apr 13 2022
- Leave a response
Both current patient data and cases reported in the literature were assessed to ascertain the frequency and presentation of myasthenia gravis in the setting of immune checkpoint inhibitor therapy.
Source: AAO
Posted in: Uncategorized
